ScreenerHero
PROGENProstatype Genomics AB (publ)
STO · SE · Healthcare · Diagnostics & Research · prostatypegenomics.com
0.1150SEK+6.98%Mkt Cap: 1.71M $P/E: —

Prostatype Genomics AB (publ) manufactures, markets, and sells prognostic gene tests. The company offers a Prostatype Test System that combines gene expression information with used clinical parameters, such as PSA, glea…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
MEDP
Medpace Holdings, Inc.
$16.98BUSDP/E 35.8
ERF
Eurofins Scientific SE
$13.64BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMerieux S.A.
$9.51BUSDP/E 19.0
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8
TWST
Twist Bioscience Corp.
$8.93BUSD

Key Statistics

Company
Market Cap1.71M $
Enterprise Value290.67K $
Revenue (TTM)56.82K $
Gross Profit56.82K $
Net Income (TTM)-4.26M $
Revenue/Share0.0017 USD
Last Price0.1150 SEK
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees7
CountrySE
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-1.28
PEG—
EV/EBITDA-0.08
EV/Revenue5.12
P/S33.65
P/B0.29
EPS (TTM)-0.50
EPS (Forward)-0.10
52W Range
0.09321% of range2.280
52W High2.280 SEK
52W Low0.0932 SEK
Profitability
Gross Margin100.00%
Oper. Margin-5423.28%
EBITDA Margin0.00%
Profit Margin-7492.09%
ROE-167.75%
ROA-87.50%
Growth
Revenue Growth-25.80%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.28M $
CapEx (TTM)1.29M $
FCF Margin-4236.81%
FCF Yield-140.67%
Net Debt-360.42K $
Net Debt/EBITDA0.10
Balance Sheet
Debt/Equity0.20
Current Ratio0.44
Quick Ratio0.40
Book Value/Sh0.4480 SEK
Cash/Share0.1530 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:1000
Split DateOct 31, 2024
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.155.57M
Float57.22M
Insiders4.69%
Institutions0.70%
Technical
SMA 500.2466 (-53.4%)
SMA 2000.6880 (-83.3%)
Beta1.41
S&P 52W Chg18.16%
Avg Vol (30d)2.56M
Avg Vol (10d)7.29M
Technical Indicators
RSI (14)35.7
MACD-0.0462
MACD Signal-0.0515
MACD Hist.+0.0054
BB Upper0.1989 SEK
BB Middle0.1428 SEK
BB Lower0.0868 SEK
BB Width78.51%
ATR (14)0.0464 SEK
Vol Ratio (20d)3.11x